Would you want to know? Public attitudes on early diagnostic testing for Alzheimer's disease

被引:0
作者
Elizabeth M Wikler
Robert J Blendon
John M Benson
机构
[1] Harvard Graduate School of Arts and Sciences,
[2] Department of Health Policy and Management,undefined
来源
Alzheimer's Research & Therapy | / 5卷
关键词
Alzheimer's disease; medical testing; predictive testing; medical decision-making; public attitudes; preclinical;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 363 条
  • [1] DeKosky ST(2011)Revision of the criteria for Alzheimer's disease: a symposium Alzheimers Dement 7 e1-e12
  • [2] Carrillo MC(2011)Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging and the Alzheimer's Association workgroup Alzheimers Dement 7 280-292
  • [3] Phelps C(2011)Dementia: challenges and promising developments Lancet Neurol 10 7-9
  • [4] Knopman D(2012)Multivariate protein signatures of pre-clinical Alzheimer's disease in the Alzheimer's disease neuroimaging initiative (ADNI) plasma proteome dataset PLoS ONE 7 e34341-32
  • [5] Petersen RC(2005)Why people use health services Milbank Mem Fund Q 83 1-1031
  • [6] Frank R(2011)Alzheimer's disease Lancet 377 1019-1356
  • [7] Schenk D(1997)Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis JAMA 278 1349-605
  • [8] Masterman D(2011)Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors Genet Med 13 597-1093
  • [9] Siemers ER(2009)Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes Nat Genet 41 1088-1840
  • [10] Cedarbaum JM(2010)Genome-wide analysis of genetic loci associated with Alzheimer's disease JAMA 303 1832-35